Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis
Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects. A literature search yielded 56 experimental studies of acute ketamine administration that...
Saved in:
Published in | Progress in neuro-psychopharmacology & biological psychiatry Vol. 118; p. 110575 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
30.08.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0278-5846 1878-4216 1878-4216 |
DOI | 10.1016/j.pnpbp.2022.110575 |
Cover
Abstract | Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects.
A literature search yielded 56 experimental studies of acute ketamine administration that assessed cognition in 1041 healthy volunteers. A multivariate meta-analysis was performed, and effect sizes were estimated for eleven cognitive domains: attention, executive function, response inhibition, social cognition, speed of processing, verbal / language, verbal learning, verbal memory, visual learning & memory, visuospatial abilities, and working memory.
There were small-to-moderate impairments across all cognitive domains. Deficits in verbal learning / memory were most prominent, whereas response inhibition was the least affected. Meta-regression analysis revealed that the negative effects of ketamine on cognition are dependent on infusion dose and plasma level, but unaffected by enantiomer type, route of administration, sex or age. A publication bias was observed.
Acute ketamine broadly impairs cognition across all domains among healthy individuals. Verbal learning and memory figures most prominently in cognitive impairment elicited by acute ketamine administration.
•Acute ketamine affects multiple cognitive domains in healthy individuals.•The most prominent ketamine-induced deficits are in verbal learning and memory.•The negative effects of acute ketamine administration are dose-dependent. |
---|---|
AbstractList | Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects.BACKGROUNDImpairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects.A literature search yielded 56 experimental studies of acute ketamine administration that assessed cognition in 1041 healthy volunteers. A multivariate meta-analysis was performed, and effect sizes were estimated for eleven cognitive domains: attention, executive function, response inhibition, social cognition, speed of processing, verbal / language, verbal learning, verbal memory, visual learning & memory, visuospatial abilities, and working memory.METHODSA literature search yielded 56 experimental studies of acute ketamine administration that assessed cognition in 1041 healthy volunteers. A multivariate meta-analysis was performed, and effect sizes were estimated for eleven cognitive domains: attention, executive function, response inhibition, social cognition, speed of processing, verbal / language, verbal learning, verbal memory, visual learning & memory, visuospatial abilities, and working memory.There were small-to-moderate impairments across all cognitive domains. Deficits in verbal learning / memory were most prominent, whereas response inhibition was the least affected. Meta-regression analysis revealed that the negative effects of ketamine on cognition are dependent on infusion dose and plasma level, but unaffected by enantiomer type, route of administration, sex or age. A publication bias was observed.RESULTSThere were small-to-moderate impairments across all cognitive domains. Deficits in verbal learning / memory were most prominent, whereas response inhibition was the least affected. Meta-regression analysis revealed that the negative effects of ketamine on cognition are dependent on infusion dose and plasma level, but unaffected by enantiomer type, route of administration, sex or age. A publication bias was observed.Acute ketamine broadly impairs cognition across all domains among healthy individuals. Verbal learning and memory figures most prominently in cognitive impairment elicited by acute ketamine administration.DISCUSSIONAcute ketamine broadly impairs cognition across all domains among healthy individuals. Verbal learning and memory figures most prominently in cognitive impairment elicited by acute ketamine administration. Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects. A literature search yielded 56 experimental studies of acute ketamine administration that assessed cognition in 1041 healthy volunteers. A multivariate meta-analysis was performed, and effect sizes were estimated for eleven cognitive domains: attention, executive function, response inhibition, social cognition, speed of processing, verbal / language, verbal learning, verbal memory, visual learning & memory, visuospatial abilities, and working memory. There were small-to-moderate impairments across all cognitive domains. Deficits in verbal learning / memory were most prominent, whereas response inhibition was the least affected. Meta-regression analysis revealed that the negative effects of ketamine on cognition are dependent on infusion dose and plasma level, but unaffected by enantiomer type, route of administration, sex or age. A publication bias was observed. Acute ketamine broadly impairs cognition across all domains among healthy individuals. Verbal learning and memory figures most prominently in cognitive impairment elicited by acute ketamine administration. •Acute ketamine affects multiple cognitive domains in healthy individuals.•The most prominent ketamine-induced deficits are in verbal learning and memory.•The negative effects of acute ketamine administration are dose-dependent. Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most prominent and what variables modulate these effects. A literature search yielded 56 experimental studies of acute ketamine administration that assessed cognition in 1041 healthy volunteers. A multivariate meta-analysis was performed, and effect sizes were estimated for eleven cognitive domains: attention, executive function, response inhibition, social cognition, speed of processing, verbal / language, verbal learning, verbal memory, visual learning & memory, visuospatial abilities, and working memory. There were small-to-moderate impairments across all cognitive domains. Deficits in verbal learning / memory were most prominent, whereas response inhibition was the least affected. Meta-regression analysis revealed that the negative effects of ketamine on cognition are dependent on infusion dose and plasma level, but unaffected by enantiomer type, route of administration, sex or age. A publication bias was observed. Acute ketamine broadly impairs cognition across all domains among healthy individuals. Verbal learning and memory figures most prominently in cognitive impairment elicited by acute ketamine administration. |
ArticleNumber | 110575 |
Author | Zhornitsky, Simon Assaf, Roxane Tourjman, Valérie Li, Chiang-Shan R. Pelletier, Julie Potvin, Stéphane |
Author_xml | – sequence: 1 givenname: Simon surname: Zhornitsky fullname: Zhornitsky, Simon organization: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA – sequence: 2 givenname: Valérie surname: Tourjman fullname: Tourjman, Valérie organization: Department of Psychiatry, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada – sequence: 3 givenname: Julie surname: Pelletier fullname: Pelletier, Julie organization: Department of Psychiatry, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada – sequence: 4 givenname: Roxane surname: Assaf fullname: Assaf, Roxane organization: Department of Psychiatry, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada – sequence: 5 givenname: Chiang-Shan R. surname: Li fullname: Li, Chiang-Shan R. organization: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA – sequence: 6 givenname: Stéphane surname: Potvin fullname: Potvin, Stéphane email: stephane.potvin@umontreal.ca organization: Department of Psychiatry, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35568275$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kE1LxDAQhoMoun78AkFy9NI1SZu0ETws4hcIXvTiJaTJVLO2aW1SYf-9WVc9ePA0M_A-w8yzj7Z97wGhY0rmlFBxtpwPfqiHOSOMzSklvORbaEarssoKRsU2mhGWel4VYg_th7AkhNCc5LtoL-dcVKzkM_S8MFMEDE0DJgbcN_gNou6cB6y9xRB-x95j0794F13qnMevoNv4usJhqpdr9hwvcJfCmfa6XQUXDtFOo9sAR9_1AD1dXz1e3mb3Dzd3l4v7zKQzYlbUQjJLypxZUQhrKJc1rblmzGpT2argssobLot0cCklLSSvKAeidZnbsiH5ATrd7B3G_n2CEFXngoG21R76KSgmRFEmCUSm6Ml3dKo7sGoYXafHlfrxkQJyEzBjH8IIjTIu6vXLcdSuVZSotXu1VF_u1dq92rhPbP6H_Vn_P3WxoSAp-nAwqmAceAPWjUmrsr37l_8ERhydKw |
CitedBy_id | crossref_primary_10_1007_s00213_024_06720_8 crossref_primary_10_3389_fphar_2024_1337749 crossref_primary_10_3389_fphar_2022_991559 crossref_primary_10_1007_s00406_023_01570_5 crossref_primary_10_1016_j_jad_2024_09_162 crossref_primary_10_1016_j_jep_2024_117774 crossref_primary_10_1080_14656566_2023_2194488 crossref_primary_10_1016_j_taap_2023_116789 crossref_primary_10_1093_ijnp_pyae046 crossref_primary_10_1177_02698811241273850 crossref_primary_10_1523_ENEURO_0015_23_2023 crossref_primary_10_3390_biom13091411 crossref_primary_10_1016_j_pnpbp_2024_111095 crossref_primary_10_1093_ijnp_pyae039 crossref_primary_10_1192_bjo_2023_577 crossref_primary_10_1016_j_jhazmat_2024_135823 crossref_primary_10_1136_bmjopen_2024_084844 crossref_primary_10_3389_fpsyt_2023_1197890 crossref_primary_10_1002_npr2_12420 crossref_primary_10_1080_02791072_2023_2190758 |
Cites_doi | 10.1177/1073858411409051 10.1523/JNEUROSCI.3147-12.2013 10.1017/S1461145714001011 10.1016/0091-3057(90)90140-D 10.1007/s00213-007-1047-x 10.1016/j.jad.2018.07.033 10.1016/j.neuroimage.2010.08.021 10.1016/j.neuropharm.2021.108614 10.1007/s00213-005-0154-9 10.1097/ALN.0b013e3181b437b1 10.1007/s00213-005-0177-2 10.1097/00001756-200303030-00018 10.1016/j.schres.2007.04.022 10.1136/bmj.b2535 10.1016/j.neuroimage.2011.06.045 10.1016/j.neulet.2009.01.065 10.1016/j.neuroimage.2005.10.031 10.1016/j.neubiorev.2017.04.005 10.1111/j.1369-1600.2011.00418.x 10.1007/s00213-013-3255-x 10.1016/S2215-0366(17)30272-9 10.1136/bmj.315.7109.629 10.1007/s40262-016-0383-6 10.1038/s41380-021-01082-5 10.1016/j.psc.2016.04.004 10.1016/j.jad.2019.08.012 10.1016/j.addbeh.2018.01.021 10.1038/s41380-018-0028-2 10.2147/DDDT.S221437 10.1038/sj.npp.1300272 10.1007/s00213-006-0572-3 10.1016/0197-2456(86)90046-2 10.1016/j.forsciint.2015.04.024 10.1523/JNEUROSCI.05-11-02909.1985 10.1002/hbm.24791 10.1097/ADM.0000000000000066 10.1213/00000539-197105000-00024 10.1016/j.ynstr.2018.09.001 10.1037/1064-1297.14.4.439 10.1001/jama.2010.605 10.1038/npp.2014.298 10.1176/appi.ajp.2016.16010037 10.1016/0006-8993(91)90460-D 10.1016/j.tics.2011.08.003 10.18637/jss.v036.i03 10.1523/JNEUROSCI.2094-18.2019 10.1002/sim.1186 10.1177/026988119601000208 10.1016/j.neulet.2019.134683 10.1016/S0893-133X(98)00067-0 10.1001/archpsyc.1994.03950030035004 10.1007/s00213-006-0409-0 10.1002/hbm.23148 10.1038/npp.2013.170 |
ContentType | Journal Article |
Copyright | 2022 Elsevier Inc. Copyright © 2022 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier Inc. – notice: Copyright © 2022 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.pnpbp.2022.110575 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1878-4216 |
ExternalDocumentID | 35568275 10_1016_j_pnpbp_2022_110575 S0278584622000677 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXLA AAXUO ABCQJ ABFRF ABIVO ABJNI ABMAC ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM L7B M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SES SSN SSP SSZ T5K TEORI ~G- .GJ 29P 53G 5VS AAQFI AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION EJD FEDTE FGOYB G-2 HMQ HMT HVGLF HZ~ R2- RIG SEW SNS SPT SSH WUQ ZGI EFKBS NPM 7X8 |
ID | FETCH-LOGICAL-c355t-4b692d0732d646dc159b1b5a22dac8d845983f5948277991495815e0aa73d7f03 |
IEDL.DBID | AIKHN |
ISSN | 0278-5846 1878-4216 |
IngestDate | Thu Sep 04 23:41:32 EDT 2025 Mon Jul 21 05:52:58 EDT 2025 Tue Jul 01 01:50:28 EDT 2025 Thu Apr 24 23:03:58 EDT 2025 Fri Feb 23 02:40:26 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Ketamine IM IN Acute administration meta-analysis NMDA PRISMA Cognition IV |
Language | English |
License | Copyright © 2022 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c355t-4b692d0732d646dc159b1b5a22dac8d845983f5948277991495815e0aa73d7f03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35568275 |
PQID | 2664784609 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2664784609 pubmed_primary_35568275 crossref_citationtrail_10_1016_j_pnpbp_2022_110575 crossref_primary_10_1016_j_pnpbp_2022_110575 elsevier_sciencedirect_doi_10_1016_j_pnpbp_2022_110575 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-30 |
PublicationDateYYYYMMDD | 2022-08-30 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Progress in neuro-psychopharmacology & biological psychiatry |
PublicationTitleAlternate | Prog Neuropsychopharmacol Biol Psychiatry |
PublicationYear | 2022 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Huang, Su, Ma (bb0095) 2020; 716 Heale, Harley (bb0080) 1990; 36 Morgan, Curran (bb0155) 2006; 188 Cohen (bb0030) 1988 Harborne, Watson, Healy, Groves (bb0075) 1996; 10 Parwani, Weiler, Blaxton, Warfel, Hardin, Frey, Lahti (bb0195) 2005; 183 Battaglia-Mayer, Caminiti (bb0020) 2019; 39 Chen, Li, Lin, Hong, Tu, Bai, Cheng, Su (bb0025) 2018; 241 Potvin, Joyal, Pelletier, Stip (bb0210) 2008; 100 Zheng, Xu, Xie, Guo, Zhang, Yao, Wu (bb0305) 2015; 386326 Strong, Kabbaj (bb0275) 2018; 21 Fu, Abel, Allin, Gasston, Costafreda, Suckling, Williams, McGuire (bb0060) 2005; 183 Walker, Gold (bb0295) 1991; 549 Stone, Erlandsson, Arstad, Squassante, Teneggi, Bressan, Krystal, Ell, Pilowsky (bb0270) 2008; 197 Sadove, Hatano, Zahed, Redlin, Arastounejad, Roman (bb0235) 1971; 50 Murrough, Burdick, Levitch, Perez, Brallier, Chang, Foulkes, Charney, Mathew, Iosifescu (bb0170) 2015; 40 Derntl, Hornung, Sen, Colic, Li, Walter (bb0040) 2019; 13 Peltoniemi, Hagelberg, Olkkola, Saari (bb0205) 2016; 55 Andrade, Arumugham, Thirthalli (bb0010) 2016; 39 Lofwall, Griffiths, Mintzer (bb0130) 2006; 14 Viechtbauer (bb0290) 2010; 36 Murrough, Wan, Iacoviello, Collins, Solon, Glicksberg, Perez, Mathew, Charney, Iosifescu, Burdick (bb0165) 2014; 231 Corriger, Pickering (bb0035) 2019; 27 Sigtermans, Dahan, Mooren, Bauer, Kest, Sarton, Olofsen (bb0255) 2009; 111 Nugent, Ballard, Gould, Park, Moaddel, Brutsche, Zarate (bb0190) 2019; 24 Krystal, Karper, Seibyl, Freeman, Delaney, Bremner, Heninger, Bowers, Charney (bb0105) 1994; 51 Potvin, Pelletier, Grot, Hébert, Barr, Lecomte (bb0220) 2018; 80 Morgan, Perry, Cho, Krystal, D’Souza (bb0160) 2006; 187 Giorgetti, Marcotulli, Tagliabracci, Schifano (bb0070) 2015; 252 Monaghan, Cotman (bb0150) 1985; 5 Egger, Smith, Schneider, Minder (bb0055) 1997; 315 Stavro, Pelletier, Potvin (bb0265) 2013; 18 Team, R.C (bb0280) 2020 Lezak, Howieson, Bigler, Tranel (bb0110) 2012 Musso, Brinkmeyer, Ecker, London, Thieme, Warbrick, Wittsack, Saleh, Greb, de Boer, Winterer (bb0175) 2011; 58 Potvin, Stavro, Rizkallah, Pelletier (bb0215) 2014; 8 Shiroma, Albott, Johns, Thuras, Wels, Lim (bb0245) 2014; 17 Paulson, Bazemore (bb0200) 2010; 303 Lie, Specht, Marshall, Fink (bb0115) 2006; 30 Driesen, McCarthy, Bhagwagar, Bloch, Calhoun, D’Souza, Gueorguieva, He, Leung, Ramani, Anticevic, Suckow, Morgan, Krystal (bb0050) 2013; 38 Nagels, Kirner-Veselinovic, Krach, Kircher (bb0180) 2011; 54 Short, Fong, Galvez, Shelker, Loo (bb0250) 2018; 5 Fusar-Poli, Placentino, Carletti, Allen, Landi, Abbamonte, Barale, Perez, McGuire, Politi (bb0065) 2009; 452 Zacharias, Musso, Müller, Lammers, Saleh, London, de Boer, Winterer (bb0300) 2020; 41 Menon (bb0140) 2011; 15 Liu, Zhou, Zheng, Wang, Zhan, Lan, Zhang, Li, Chen, Ning (bb0125) 2019; 259 DerSimonian, Laird (bb0045) 1986; 7 Ptak (bb0225) 2012; 18 Singh, Fedgchin, Daly, De Boer, Cooper, Lim, Pinter, Murrough, Sanacora, Shelton, Kurian, Winokur, Fava, Manji, Drevets, Van Nueten (bb0260) 2016; 173 Manoliu, Meng, Brandl, Doll, Tahmasian, Scherr, Schwerthoffer, Zimmer, Forstl, Bauml, Riedl, Wohlschlager, Sorg (bb0135) 2013; 7 Roussy, Luna, Duong, Corrigan, Gulli, Nogueira, Moreno-Bote, Sachs, Palaniyappan, Martinez-Trujillo (bb0230) 2021; 26 Honey, Turner, Honey, Sharar, Kumaran, Pomarol-Clotet, McKenna, Sahakian, Robbins, Fletcher (bb0090) 2003; 28 Thomas, Bozaoglu, Rossell, Gurvich (bb0285) 2017; 77 Newcomer, Farber, Jevtovic-Todorovic, Selke, Melson, Hershey, Craft, Olney (bb0185) 1999; 20 Lipsey, Wilson (bb0120) 2000 Katzev, Tüscher, Hennig, Weiller, Kaller (bb0100) 2013; 33 Higgins, Thompson (bb0085) 2002; 21 Scheidegger, Henning, Walter, Lehmann, Kraehenmann, Boeker, Seifritz, Grimm (bb0240) 2016; 37 Moher, Liberati, Tetzlaff, Altman (bb0145) 2009; 339 Abel, Allin, Kucharska-Pietura, David, Andrew, Williams, Brammer, Phillips (bb0005) 2003; 14 Banks, Bashir (bb0015) 2021; 192 Sadove (10.1016/j.pnpbp.2022.110575_bb0235) 1971; 50 Team, R.C (10.1016/j.pnpbp.2022.110575_bb0280) 2020 Derntl (10.1016/j.pnpbp.2022.110575_bb0040) 2019; 13 Stone (10.1016/j.pnpbp.2022.110575_bb0270) 2008; 197 Thomas (10.1016/j.pnpbp.2022.110575_bb0285) 2017; 77 Musso (10.1016/j.pnpbp.2022.110575_bb0175) 2011; 58 Egger (10.1016/j.pnpbp.2022.110575_bb0055) 1997; 315 Short (10.1016/j.pnpbp.2022.110575_bb0250) 2018; 5 Heale (10.1016/j.pnpbp.2022.110575_bb0080) 1990; 36 Banks (10.1016/j.pnpbp.2022.110575_bb0015) 2021; 192 Shiroma (10.1016/j.pnpbp.2022.110575_bb0245) 2014; 17 DerSimonian (10.1016/j.pnpbp.2022.110575_bb0045) 1986; 7 Murrough (10.1016/j.pnpbp.2022.110575_bb0170) 2015; 40 Stavro (10.1016/j.pnpbp.2022.110575_bb0265) 2013; 18 Menon (10.1016/j.pnpbp.2022.110575_bb0140) 2011; 15 Sigtermans (10.1016/j.pnpbp.2022.110575_bb0255) 2009; 111 Lipsey (10.1016/j.pnpbp.2022.110575_bb0120) 2000 Paulson (10.1016/j.pnpbp.2022.110575_bb0200) 2010; 303 Lezak (10.1016/j.pnpbp.2022.110575_bb0110) 2012 Fu (10.1016/j.pnpbp.2022.110575_bb0060) 2005; 183 Liu (10.1016/j.pnpbp.2022.110575_bb0125) 2019; 259 Zacharias (10.1016/j.pnpbp.2022.110575_bb0300) 2020; 41 Monaghan (10.1016/j.pnpbp.2022.110575_bb0150) 1985; 5 Strong (10.1016/j.pnpbp.2022.110575_bb0275) 2018; 21 Viechtbauer (10.1016/j.pnpbp.2022.110575_bb0290) 2010; 36 Walker (10.1016/j.pnpbp.2022.110575_bb0295) 1991; 549 Andrade (10.1016/j.pnpbp.2022.110575_bb0010) 2016; 39 Singh (10.1016/j.pnpbp.2022.110575_bb0260) 2016; 173 Driesen (10.1016/j.pnpbp.2022.110575_bb0050) 2013; 38 Honey (10.1016/j.pnpbp.2022.110575_bb0090) 2003; 28 Higgins (10.1016/j.pnpbp.2022.110575_bb0085) 2002; 21 Huang (10.1016/j.pnpbp.2022.110575_bb0095) 2020; 716 Nagels (10.1016/j.pnpbp.2022.110575_bb0180) 2011; 54 Battaglia-Mayer (10.1016/j.pnpbp.2022.110575_bb0020) 2019; 39 Fusar-Poli (10.1016/j.pnpbp.2022.110575_bb0065) 2009; 452 Moher (10.1016/j.pnpbp.2022.110575_bb0145) 2009; 339 Harborne (10.1016/j.pnpbp.2022.110575_bb0075) 1996; 10 Katzev (10.1016/j.pnpbp.2022.110575_bb0100) 2013; 33 Abel (10.1016/j.pnpbp.2022.110575_bb0005) 2003; 14 Scheidegger (10.1016/j.pnpbp.2022.110575_bb0240) 2016; 37 Parwani (10.1016/j.pnpbp.2022.110575_bb0195) 2005; 183 Potvin (10.1016/j.pnpbp.2022.110575_bb0215) 2014; 8 Cohen (10.1016/j.pnpbp.2022.110575_bb0030) 1988 Morgan (10.1016/j.pnpbp.2022.110575_bb0160) 2006; 187 Chen (10.1016/j.pnpbp.2022.110575_bb0025) 2018; 241 Ptak (10.1016/j.pnpbp.2022.110575_bb0225) 2012; 18 Corriger (10.1016/j.pnpbp.2022.110575_bb0035) 2019; 27 Giorgetti (10.1016/j.pnpbp.2022.110575_bb0070) 2015; 252 Potvin (10.1016/j.pnpbp.2022.110575_bb0210) 2008; 100 Lie (10.1016/j.pnpbp.2022.110575_bb0115) 2006; 30 Manoliu (10.1016/j.pnpbp.2022.110575_bb0135) 2013; 7 Murrough (10.1016/j.pnpbp.2022.110575_bb0165) 2014; 231 Lofwall (10.1016/j.pnpbp.2022.110575_bb0130) 2006; 14 Peltoniemi (10.1016/j.pnpbp.2022.110575_bb0205) 2016; 55 Nugent (10.1016/j.pnpbp.2022.110575_bb0190) 2019; 24 Zheng (10.1016/j.pnpbp.2022.110575_bb0305) 2015; 386326 Krystal (10.1016/j.pnpbp.2022.110575_bb0105) 1994; 51 Newcomer (10.1016/j.pnpbp.2022.110575_bb0185) 1999; 20 Roussy (10.1016/j.pnpbp.2022.110575_bb0230) 2021; 26 Morgan (10.1016/j.pnpbp.2022.110575_bb0155) 2006; 188 Potvin (10.1016/j.pnpbp.2022.110575_bb0220) 2018; 80 |
References_xml | – volume: 259 start-page: 1 year: 2019 end-page: 6 ident: bb0125 article-title: Repeated intravenous infusions of ketamine: neurocognition in patients with anxious and nonanxious treatment-resistant depression publication-title: J. Affect. Disord. – volume: 8 start-page: 368 year: 2014 end-page: 376 ident: bb0215 article-title: Cocaine and cognition: a systematic quantitative review publication-title: J. Addict. Med. – volume: 24 start-page: 1040 year: 2019 end-page: 1052 ident: bb0190 article-title: Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects publication-title: Mol. Psychiatry – volume: 20 start-page: 106 year: 1999 end-page: 118 ident: bb0185 article-title: Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis publication-title: Neuropsychopharmacology – volume: 452 start-page: 262 year: 2009 end-page: 267 ident: bb0065 article-title: Laterality effect on emotional faces processing: ALE meta-analysis of evidence publication-title: Neurosci. Lett. – volume: 80 start-page: 154 year: 2018 end-page: 160 ident: bb0220 article-title: Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis publication-title: Addict. Behav. – year: 2000 ident: bb0120 article-title: Practical Meta-Analysis (Applied Social Research Methods) – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: bb0045 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials – volume: 13 year: 2019 ident: bb0040 article-title: Interaction of sex and age on the dissociative effects of ketamine action in young healthy participants publication-title: Front. Neurosci. – volume: 58 start-page: 508 year: 2011 end-page: 525 ident: bb0175 article-title: Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task publication-title: Neuroimage – volume: 27 start-page: 3051 year: 2019 end-page: 3067 ident: bb0035 article-title: Ketamine and depression: a narrative review publication-title: Drug Des Devel Ther – volume: 15 start-page: 483 year: 2011 end-page: 506 ident: bb0140 article-title: Large-scale brain networks and psychopathology: a unifying triple network model publication-title: Trends Cogn. Sci. – volume: 17 start-page: 1805 year: 2014 end-page: 1813 ident: bb0245 article-title: Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression publication-title: Int. J. Neuropsychopharmacol. – volume: 21 start-page: 166 year: 2018 end-page: 175 ident: bb0275 article-title: On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods publication-title: Neurobiol Stress – volume: 231 start-page: 481 year: 2014 end-page: 488 ident: bb0165 article-title: Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response publication-title: Psychopharmacology (Berl) – volume: 38 start-page: 2613 year: 2013 end-page: 2622 ident: bb0050 article-title: The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity publication-title: Neuropsychopharmacology – volume: 183 start-page: 265 year: 2005 end-page: 274 ident: bb0195 article-title: The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers publication-title: Psychopharmacology – volume: 50 start-page: 388 year: 1971 end-page: 393 ident: bb0235 article-title: Clinical study of droperidol in the prevention of the side effects of ketamine anesthesia: a preliminary report publication-title: Anesth. Analg. – year: 2012 ident: bb0110 article-title: Neuropsychological Assessment – volume: 192 year: 2021 ident: bb0015 article-title: NMDARs in prefrontal cortex - regulation of synaptic transmission and plasticity publication-title: Neuropharmacology – volume: 187 start-page: 405 year: 2006 end-page: 414 ident: bb0160 article-title: Greater vulnerability to the amnestic effects of ketamine in males publication-title: Psychopharmacology – volume: 241 start-page: 1 year: 2018 end-page: 7 ident: bb0025 article-title: Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion publication-title: J. Affect. Disord. – volume: 10 start-page: 134 year: 1996 end-page: 140 ident: bb0075 article-title: The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers publication-title: J. Psychopharmacol. – volume: 18 start-page: 203 year: 2013 end-page: 213 ident: bb0265 article-title: Widespread and sustained cognitive deficits in alcoholism: a meta-analysis publication-title: Addict. Biol. – volume: 173 start-page: 816 year: 2016 end-page: 826 ident: bb0260 article-title: A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression publication-title: Am. J. Psychiatry – volume: 252 start-page: 127 year: 2015 end-page: 142 ident: bb0070 article-title: Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability publication-title: Forensic Sci. Int. – volume: 28 start-page: 2037 year: 2003 end-page: 2044 ident: bb0090 article-title: Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory publication-title: Neuropsychopharmacology – volume: 14 start-page: 387 year: 2003 end-page: 391 ident: bb0005 article-title: Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study publication-title: Neuroreport – volume: 5 start-page: 2909 year: 1985 end-page: 2919 ident: bb0150 article-title: Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain publication-title: J. Neurosci. – volume: 7 start-page: 930 year: 2013 ident: bb0135 article-title: Insular dysfunction within the salience network is associated with severity of symptoms and aberrant inter-network connectivity in major depressive disorder publication-title: Front. Hum. Neurosci. – volume: 30 start-page: 1038 year: 2006 end-page: 1049 ident: bb0115 article-title: Using fMRI to decompose the neural processes underlying the Wisconsin card sorting test publication-title: Neuroimage – volume: 41 start-page: 107 year: 2020 end-page: 119 ident: bb0300 article-title: Ketamine effects on default mode network activity and vigilance: a randomized, placebo-controlled crossover simultaneous fMRI/EEG study publication-title: Hum. Brain Mapp. – year: 1988 ident: bb0030 article-title: Statistical Power Analysis for the Behavioral Sciences – volume: 197 start-page: 401 year: 2008 end-page: 408 ident: bb0270 article-title: Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study publication-title: Psychopharmacology – volume: 183 start-page: 92 year: 2005 end-page: 102 ident: bb0060 article-title: Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study publication-title: Psychopharmacology – volume: 549 start-page: 213 year: 1991 end-page: 221 ident: bb0295 article-title: Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory publication-title: Brain Res. – volume: 39 start-page: 4404 year: 2019 end-page: 4421 ident: bb0020 article-title: Corticocortical systems underlying high-order motor control publication-title: J. Neurosci. – volume: 386326 year: 2015 ident: bb0305 article-title: The altered triple networks interaction in depression under resting state based on graph theory publication-title: Biomed. Res. Int. – volume: 18 start-page: 502 year: 2012 end-page: 515 ident: bb0225 article-title: The frontoparietal attention network of the human brain: action, saliency, and a priority map of the environment publication-title: Neuroscientist – volume: 36 start-page: 1 year: 2010 end-page: 48 ident: bb0290 article-title: Conducting Meta-analyses in R with the metafor package publication-title: J. Stat. Softw. – volume: 39 start-page: 513 year: 2016 end-page: 530 ident: bb0010 article-title: Adverse effects of electroconvulsive therapy publication-title: Psychiatr Clin North Am – volume: 51 start-page: 199 year: 1994 end-page: 214 ident: bb0105 article-title: Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses publication-title: Arch. Gen. Psychiatry – volume: 5 start-page: 65 year: 2018 end-page: 78 ident: bb0250 article-title: Side-effects associated with ketamine use in depression: a systematic review publication-title: Lancet Psychiatry – volume: 54 start-page: 1307 year: 2011 end-page: 1314 ident: bb0180 article-title: Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency publication-title: NeuroImage – volume: 303 start-page: 1961 year: 2010 end-page: 1969 ident: bb0200 article-title: Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis publication-title: Jama – volume: 21 start-page: 1539 year: 2002 end-page: 1558 ident: bb0085 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat. Med. – volume: 33 start-page: 7837 year: 2013 end-page: 7845 ident: bb0100 article-title: Revisiting the functional specialization of left inferior frontal gyrus in phonological and semantic fluency: the crucial role of task demands and individual ability publication-title: J. Neurosci. – volume: 100 start-page: 242 year: 2008 end-page: 251 ident: bb0210 article-title: Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis publication-title: Schizophr. Res. – volume: 26 start-page: 6688 year: 2021 end-page: 6703 ident: bb0230 article-title: Ketamine disrupts naturalistic coding of working memory in primate lateral prefrontal cortex networks publication-title: Mol. Psychiatry – volume: 315 start-page: 629 year: 1997 end-page: 634 ident: bb0055 article-title: Bias in meta-analysis detected by a simple, graphical test publication-title: BMJ – volume: 40 start-page: 1084 year: 2015 end-page: 1090 ident: bb0170 article-title: Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial publication-title: Neuropsychopharmacology – volume: 77 start-page: 369 year: 2017 end-page: 387 ident: bb0285 article-title: The influence of the glutamatergic system on cognition in schizophrenia: a systematic review publication-title: Neurosci. Biobehav. Rev. – volume: 36 start-page: 145 year: 1990 end-page: 149 ident: bb0080 article-title: MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze publication-title: Pharmacol. Biochem. Behav. – year: 2020 ident: bb0280 article-title: R: A Language and Environment for Statistical Computing – volume: 339 year: 2009 ident: bb0145 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: BMJ – volume: 716 year: 2020 ident: bb0095 article-title: The Stroop effect: an activation likelihood estimation meta-analysis in healthy young adults publication-title: Neurosci. Lett. – volume: 55 start-page: 1059 year: 2016 end-page: 1077 ident: bb0205 article-title: Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy publication-title: Clin. Pharmacokinet. – volume: 111 start-page: 892 year: 2009 end-page: 903 ident: bb0255 article-title: S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers publication-title: Anesthesiology – volume: 188 start-page: 408 year: 2006 end-page: 424 ident: bb0155 article-title: Acute and chronic effects of ketamine upon human memory: a review publication-title: Psychopharmacology – volume: 37 start-page: 1941 year: 2016 end-page: 1952 ident: bb0240 article-title: Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation publication-title: Hum. Brain Mapp. – volume: 14 start-page: 439 year: 2006 end-page: 449 ident: bb0130 article-title: Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults publication-title: Exp. Clin. Psychopharmacol. – volume: 18 start-page: 502 issue: 5 year: 2012 ident: 10.1016/j.pnpbp.2022.110575_bb0225 article-title: The frontoparietal attention network of the human brain: action, saliency, and a priority map of the environment publication-title: Neuroscientist doi: 10.1177/1073858411409051 – volume: 33 start-page: 7837 issue: 18 year: 2013 ident: 10.1016/j.pnpbp.2022.110575_bb0100 article-title: Revisiting the functional specialization of left inferior frontal gyrus in phonological and semantic fluency: the crucial role of task demands and individual ability publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3147-12.2013 – volume: 17 start-page: 1805 issue: 11 year: 2014 ident: 10.1016/j.pnpbp.2022.110575_bb0245 article-title: Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression publication-title: Int. J. Neuropsychopharmacol. doi: 10.1017/S1461145714001011 – volume: 36 start-page: 145 issue: 1 year: 1990 ident: 10.1016/j.pnpbp.2022.110575_bb0080 article-title: MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/0091-3057(90)90140-D – volume: 197 start-page: 401 issue: 3 year: 2008 ident: 10.1016/j.pnpbp.2022.110575_bb0270 article-title: Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study publication-title: Psychopharmacology doi: 10.1007/s00213-007-1047-x – volume: 241 start-page: 1 year: 2018 ident: 10.1016/j.pnpbp.2022.110575_bb0025 article-title: Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2018.07.033 – volume: 54 start-page: 1307 issue: 2 year: 2011 ident: 10.1016/j.pnpbp.2022.110575_bb0180 article-title: Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency publication-title: NeuroImage doi: 10.1016/j.neuroimage.2010.08.021 – volume: 192 year: 2021 ident: 10.1016/j.pnpbp.2022.110575_bb0015 article-title: NMDARs in prefrontal cortex - regulation of synaptic transmission and plasticity publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2021.108614 – volume: 183 start-page: 92 issue: 1 year: 2005 ident: 10.1016/j.pnpbp.2022.110575_bb0060 article-title: Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study publication-title: Psychopharmacology doi: 10.1007/s00213-005-0154-9 – volume: 111 start-page: 892 issue: 4 year: 2009 ident: 10.1016/j.pnpbp.2022.110575_bb0255 article-title: S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers publication-title: Anesthesiology doi: 10.1097/ALN.0b013e3181b437b1 – volume: 183 start-page: 265 issue: 3 year: 2005 ident: 10.1016/j.pnpbp.2022.110575_bb0195 article-title: The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers publication-title: Psychopharmacology doi: 10.1007/s00213-005-0177-2 – volume: 14 start-page: 387 issue: 3 year: 2003 ident: 10.1016/j.pnpbp.2022.110575_bb0005 article-title: Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study publication-title: Neuroreport doi: 10.1097/00001756-200303030-00018 – volume: 100 start-page: 242 issue: 1–3 year: 2008 ident: 10.1016/j.pnpbp.2022.110575_bb0210 article-title: Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis publication-title: Schizophr. Res. doi: 10.1016/j.schres.2007.04.022 – volume: 7 start-page: 930 year: 2013 ident: 10.1016/j.pnpbp.2022.110575_bb0135 article-title: Insular dysfunction within the salience network is associated with severity of symptoms and aberrant inter-network connectivity in major depressive disorder publication-title: Front. Hum. Neurosci. – volume: 339 year: 2009 ident: 10.1016/j.pnpbp.2022.110575_bb0145 article-title: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: BMJ doi: 10.1136/bmj.b2535 – volume: 58 start-page: 508 issue: 2 year: 2011 ident: 10.1016/j.pnpbp.2022.110575_bb0175 article-title: Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task publication-title: Neuroimage doi: 10.1016/j.neuroimage.2011.06.045 – volume: 452 start-page: 262 issue: 3 year: 2009 ident: 10.1016/j.pnpbp.2022.110575_bb0065 article-title: Laterality effect on emotional faces processing: ALE meta-analysis of evidence publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2009.01.065 – volume: 30 start-page: 1038 issue: 3 year: 2006 ident: 10.1016/j.pnpbp.2022.110575_bb0115 article-title: Using fMRI to decompose the neural processes underlying the Wisconsin card sorting test publication-title: Neuroimage doi: 10.1016/j.neuroimage.2005.10.031 – volume: 77 start-page: 369 year: 2017 ident: 10.1016/j.pnpbp.2022.110575_bb0285 article-title: The influence of the glutamatergic system on cognition in schizophrenia: a systematic review publication-title: Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2017.04.005 – volume: 18 start-page: 203 issue: 2 year: 2013 ident: 10.1016/j.pnpbp.2022.110575_bb0265 article-title: Widespread and sustained cognitive deficits in alcoholism: a meta-analysis publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2011.00418.x – volume: 231 start-page: 481 year: 2014 ident: 10.1016/j.pnpbp.2022.110575_bb0165 article-title: Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-013-3255-x – volume: 5 start-page: 65 issue: 1 year: 2018 ident: 10.1016/j.pnpbp.2022.110575_bb0250 article-title: Side-effects associated with ketamine use in depression: a systematic review publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(17)30272-9 – volume: 13 issue: 616 year: 2019 ident: 10.1016/j.pnpbp.2022.110575_bb0040 article-title: Interaction of sex and age on the dissociative effects of ketamine action in young healthy participants publication-title: Front. Neurosci. – volume: 315 start-page: 629 issue: 7109 year: 1997 ident: 10.1016/j.pnpbp.2022.110575_bb0055 article-title: Bias in meta-analysis detected by a simple, graphical test publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 55 start-page: 1059 issue: 9 year: 2016 ident: 10.1016/j.pnpbp.2022.110575_bb0205 article-title: Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy publication-title: Clin. Pharmacokinet. doi: 10.1007/s40262-016-0383-6 – volume: 26 start-page: 6688 issue: 11 year: 2021 ident: 10.1016/j.pnpbp.2022.110575_bb0230 article-title: Ketamine disrupts naturalistic coding of working memory in primate lateral prefrontal cortex networks publication-title: Mol. Psychiatry doi: 10.1038/s41380-021-01082-5 – volume: 39 start-page: 513 issue: 3 year: 2016 ident: 10.1016/j.pnpbp.2022.110575_bb0010 article-title: Adverse effects of electroconvulsive therapy publication-title: Psychiatr Clin North Am doi: 10.1016/j.psc.2016.04.004 – volume: 259 start-page: 1 year: 2019 ident: 10.1016/j.pnpbp.2022.110575_bb0125 article-title: Repeated intravenous infusions of ketamine: neurocognition in patients with anxious and nonanxious treatment-resistant depression publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2019.08.012 – volume: 80 start-page: 154 year: 2018 ident: 10.1016/j.pnpbp.2022.110575_bb0220 article-title: Cognitive deficits in individuals with methamphetamine use disorder: a meta-analysis publication-title: Addict. Behav. doi: 10.1016/j.addbeh.2018.01.021 – year: 2012 ident: 10.1016/j.pnpbp.2022.110575_bb0110 – year: 2020 ident: 10.1016/j.pnpbp.2022.110575_bb0280 – year: 1988 ident: 10.1016/j.pnpbp.2022.110575_bb0030 – volume: 24 start-page: 1040 issue: 7 year: 2019 ident: 10.1016/j.pnpbp.2022.110575_bb0190 article-title: Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects publication-title: Mol. Psychiatry doi: 10.1038/s41380-018-0028-2 – volume: 27 start-page: 3051 issue: 13 year: 2019 ident: 10.1016/j.pnpbp.2022.110575_bb0035 article-title: Ketamine and depression: a narrative review publication-title: Drug Des Devel Ther doi: 10.2147/DDDT.S221437 – volume: 28 start-page: 2037 issue: 11 year: 2003 ident: 10.1016/j.pnpbp.2022.110575_bb0090 article-title: Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300272 – volume: 188 start-page: 408 issue: 4 year: 2006 ident: 10.1016/j.pnpbp.2022.110575_bb0155 article-title: Acute and chronic effects of ketamine upon human memory: a review publication-title: Psychopharmacology doi: 10.1007/s00213-006-0572-3 – volume: 7 start-page: 177 issue: 3 year: 1986 ident: 10.1016/j.pnpbp.2022.110575_bb0045 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials doi: 10.1016/0197-2456(86)90046-2 – year: 2000 ident: 10.1016/j.pnpbp.2022.110575_bb0120 – volume: 252 start-page: 127 year: 2015 ident: 10.1016/j.pnpbp.2022.110575_bb0070 article-title: Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability publication-title: Forensic Sci. Int. doi: 10.1016/j.forsciint.2015.04.024 – volume: 5 start-page: 2909 issue: 11 year: 1985 ident: 10.1016/j.pnpbp.2022.110575_bb0150 article-title: Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.05-11-02909.1985 – volume: 41 start-page: 107 issue: 1 year: 2020 ident: 10.1016/j.pnpbp.2022.110575_bb0300 article-title: Ketamine effects on default mode network activity and vigilance: a randomized, placebo-controlled crossover simultaneous fMRI/EEG study publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.24791 – volume: 8 start-page: 368 issue: 5 year: 2014 ident: 10.1016/j.pnpbp.2022.110575_bb0215 article-title: Cocaine and cognition: a systematic quantitative review publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000066 – volume: 50 start-page: 388 issue: 3 year: 1971 ident: 10.1016/j.pnpbp.2022.110575_bb0235 article-title: Clinical study of droperidol in the prevention of the side effects of ketamine anesthesia: a preliminary report publication-title: Anesth. Analg. doi: 10.1213/00000539-197105000-00024 – volume: 21 start-page: 166 issue: 9 year: 2018 ident: 10.1016/j.pnpbp.2022.110575_bb0275 article-title: On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods publication-title: Neurobiol Stress doi: 10.1016/j.ynstr.2018.09.001 – volume: 14 start-page: 439 issue: 4 year: 2006 ident: 10.1016/j.pnpbp.2022.110575_bb0130 article-title: Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults publication-title: Exp. Clin. Psychopharmacol. doi: 10.1037/1064-1297.14.4.439 – volume: 303 start-page: 1961 issue: 19 year: 2010 ident: 10.1016/j.pnpbp.2022.110575_bb0200 article-title: Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis publication-title: Jama doi: 10.1001/jama.2010.605 – volume: 40 start-page: 1084 issue: 5 year: 2015 ident: 10.1016/j.pnpbp.2022.110575_bb0170 article-title: Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.298 – volume: 173 start-page: 816 issue: 8 year: 2016 ident: 10.1016/j.pnpbp.2022.110575_bb0260 article-title: A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.2016.16010037 – volume: 549 start-page: 213 issue: 2 year: 1991 ident: 10.1016/j.pnpbp.2022.110575_bb0295 article-title: Effects of the novel NMDA antagonist, NPC 12626, on long-term potentiation, learning and memory publication-title: Brain Res. doi: 10.1016/0006-8993(91)90460-D – volume: 15 start-page: 483 year: 2011 ident: 10.1016/j.pnpbp.2022.110575_bb0140 article-title: Large-scale brain networks and psychopathology: a unifying triple network model publication-title: Trends Cogn. Sci. doi: 10.1016/j.tics.2011.08.003 – volume: 36 start-page: 1 issue: 3 year: 2010 ident: 10.1016/j.pnpbp.2022.110575_bb0290 article-title: Conducting Meta-analyses in R with the metafor package publication-title: J. Stat. Softw. doi: 10.18637/jss.v036.i03 – volume: 39 start-page: 4404 issue: 23 year: 2019 ident: 10.1016/j.pnpbp.2022.110575_bb0020 article-title: Corticocortical systems underlying high-order motor control publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2094-18.2019 – volume: 21 start-page: 1539 issue: 11 year: 2002 ident: 10.1016/j.pnpbp.2022.110575_bb0085 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat. Med. doi: 10.1002/sim.1186 – volume: 10 start-page: 134 issue: 2 year: 1996 ident: 10.1016/j.pnpbp.2022.110575_bb0075 article-title: The effects of sub-anaesthetic doses of ketamine on memory, cognitive performance and subjective experience in healthy volunteers publication-title: J. Psychopharmacol. doi: 10.1177/026988119601000208 – volume: 716 year: 2020 ident: 10.1016/j.pnpbp.2022.110575_bb0095 article-title: The Stroop effect: an activation likelihood estimation meta-analysis in healthy young adults publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2019.134683 – volume: 20 start-page: 106 issue: 2 year: 1999 ident: 10.1016/j.pnpbp.2022.110575_bb0185 article-title: Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(98)00067-0 – volume: 51 start-page: 199 issue: 3 year: 1994 ident: 10.1016/j.pnpbp.2022.110575_bb0105 article-title: Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1994.03950030035004 – volume: 386326 year: 2015 ident: 10.1016/j.pnpbp.2022.110575_bb0305 article-title: The altered triple networks interaction in depression under resting state based on graph theory publication-title: Biomed. Res. Int. – volume: 187 start-page: 405 issue: 4 year: 2006 ident: 10.1016/j.pnpbp.2022.110575_bb0160 article-title: Greater vulnerability to the amnestic effects of ketamine in males publication-title: Psychopharmacology doi: 10.1007/s00213-006-0409-0 – volume: 37 start-page: 1941 issue: 5 year: 2016 ident: 10.1016/j.pnpbp.2022.110575_bb0240 article-title: Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.23148 – volume: 38 start-page: 2613 issue: 13 year: 2013 ident: 10.1016/j.pnpbp.2022.110575_bb0050 article-title: The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity publication-title: Neuropsychopharmacology doi: 10.1038/npp.2013.170 |
SSID | ssj0001303 |
Score | 2.483678 |
Snippet | Impairment in cognition is frequently associated with acute ketamine administration. However, some questions remain unanswered as to which deficits are most... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 110575 |
SubjectTerms | Acute administration Cognition Ketamine meta-analysis |
Title | Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis |
URI | https://dx.doi.org/10.1016/j.pnpbp.2022.110575 https://www.ncbi.nlm.nih.gov/pubmed/35568275 https://www.proquest.com/docview/2664784609 |
Volume | 118 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SzaWX0vS5zQMVSk7rrq2nldsSGrYtDYEmEHoRsiXDpo13ib2HvfS3d2TLGwptDsUXy0hYaKSZT6OZTwDvJSszp2mZVDKTuEFxNLFM85D6pKtKiEKzkCj89ULOr_nnG3GzA2dDLkwIq4y6v9fpnbaOX6ZxNKerxWL6LZyZBfNJ-2wTtQt7lGkpRrA3-_RlfrFVyEFNd64WFZKMuBzIh7owr1W9KgJvJaUhIl6EeMO_G6h_AdDOEJ0_g6cRQZJZ38l92PH1czi57CmoNxNy9ZBR1UzICbl8IKfevIDvs3LdehLDOMiyIj98a-8QaxJbO-KbbXFZkxhbhG-LmvQZkxvSrIvgu2lOyYzcYeXERl6Tl3B9_vHqbJ7E-xWSElFGm_BCaupwjVMnuXQlIpsiK4Sl1NkydzkXOmdV4HOhSiGOxL1UngmfWquYU1XKXsGoXtb-DZAMW-tCMHwcVw4XOUdDl1tbaq5t6sdAh0E1ZSQfD3dg_DRDlNmt6SRhgiRML4kxTLaNVj33xuPV5SAt88cUMmgdHm_4bpCtwcUVTkxs7ZfrxiB64QpnTKrH8LoX-rYnLHC3USXe_u9vD-BJKHUO6vQQRu392h8hwmmLY9j98Cs7jvP4N_Fa-EY |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKOcAFlWeX8jAS6mnDJn7G3FYV1QJtVYmtVHGxnNiRFmh2RbKHvfDbmUmcXSFBDyiXPGzF8tiez_Y3nwl5q3iZecPKpFKZggmKZ4njRmDok6kqKQvDMVD4_ELNrsSna3m9R06GWBikVcaxvx_Tu9E6vpnE2pysFovJF9wzQ_fJ-mgTfYfcFZJr5PW9-7XjeeAg3S20aAwxEmqQHupIXqt6VaBqJWPIh5fINvy7e_oX_Ozc0OkBeRDxI532RXxI9kL9iBxf9gLUmzGd7-KpmjE9ppc7aerNY_J1Wq7bQCOJgy4r-j207gaQJnW1p6HZPi5rGplFcLeoaR8vuaHNusCVm-Y9ndIbSJy4qGryhFydfpifzJJ4ukJSAsZoE1Eowzz0cOaVUL4EXFNkhXSMeVfmPhfS5LxCNRemNaBImEnlmQypc5p7XaX8Kdmvl3U4JDSD3KaQHC4vtIcuLsDN5c6VRhiXhhFhQ6XaMkqP4wkYP-zAMftmO0tYtITtLTEi422mVa-8cXtyNVjL_tGALPiG2zO-GWxroWvhfomrw3LdWMAuQkOLSc2IPOuNvi0JR-U2puXz__3ta3JvNj8_s2cfLz4fkfv4pVuqTl-Q_fbnOrwErNMWr7q2_BsIDPkR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+effects+of+ketamine+and+esketamine+on+cognition+in+healthy+subjects%3A+A+meta-analysis&rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&rft.au=Zhornitsky%2C+Simon&rft.au=Tourjman%2C+Val%C3%A9rie&rft.au=Pelletier%2C+Julie&rft.au=Assaf%2C+Roxane&rft.date=2022-08-30&rft.issn=0278-5846&rft.volume=118&rft.spage=110575&rft_id=info:doi/10.1016%2Fj.pnpbp.2022.110575&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_pnpbp_2022_110575 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-5846&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-5846&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-5846&client=summon |